If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.50    0.00 (0.00%)
Bid:
48.00
Ask:
49.00
Spread: 1.00 (2.083%)
Market Cap: £7.38m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Board Changes

Today 07:00

RNS Number : 2289L
Transense Technologies PLC
07 July 2026
 

7 July 2026

Transense Technologies plc

("Transense" or the "Company")

Board Changes

Retirement of Chief Financial Officer and Appointment of Finance Director (designate)

Transense Technologies plc (AIM: TRT), the provider of specialist sensor technology and measurement solutions, announces that Melvyn Segal has informed the Board of his intention to retire from the role of Chief Financial Officer ("CFO") and Company Secretary with effect from the Company's Annual General Meeting (AGM) in November 2026. The Board also announces the appointment of Richard Michael Pearce ACA as Finance Director with effect from 1 September 2026.

Melvyn will remain with the Company in an executive capacity for a handover period until the AGM, and will subsequently remain on the Board as a non-executive director for a further year. The Board would like to thank Melvyn for his significant contribution to Transense over many years, during which the Company and its prospects have been transformed.

Richard brings over twenty years of financial, commercial and listed company experience to Transense. Since qualifying as a Chartered Accountant with Ernst & Young in 1999, he has held senior finance roles at GE Healthcare and TD Williamson, and most recently as Finance Director at Lombard Medical where he oversaw a scale-up in revenues from £6m to £25m per annum since 2018. He will initially work alongside Melvyn in a non-board role as Finance Director, with progression to the Board leading the Group's finance function when Melvyn's steps down as CFO in November 2026.

The Board welcomes Richard to his new role and we look forward to his contribution to delivery of the future growth strategy.

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Investor Relations

(see below)

Cavendish Capital Market Limited (Nominated Adviser and Broker)

Adrian Hadden / Callum Davidson (Corporate Finance)

Jasper Berry (Sales)

0207 220 0500

Investor Relations

Anice McNamee

Tel: +44 (0)1869 238380

Investor.relations@transense.co.uk

Notes to Editors:

Transense is headquartered in Oxfordshire, UK and its shares are traded on AIM, a market operated by the London Stock Exchange (AIM: TRT). The Company develops and supplies advanced sensor technology and measurement solutions used by some of the world's leading companies to improve performance, efficiency, and safety in demanding, mission critical applications. Transense currently operates through two active business segments:

· SAWsense - designs, supplies and licences advanced sensor solutions based on proven, patent protected Surface Acoustic Wave (SAW) technology to world leading companies in aerospace, automotive, and industrial machinery (including robotics), enabling improved efficiency and performance of their products. Key customers include GE Aerospace, Parker Meggitt, McLaren Applied, Airbus and several other confidential Tier One automotive, aerospace and industrial machinery suppliers.

 

· Translogik - develops smart, connected commercial vehicle tyre inspection equipment to many of the world's leading tyre suppliers, fleet operators and service centres. Enabling accurate measurement and digital capture of safety-critical tyre condition data, used to reduce operating costs, improve safety and provide audit records for regulatory compliance. Key customers include Bridgestone, Goodyear, Continental and Prometeon (Pirelli), and leading independent providers of vehicle fleet maintenance management software.

 In addition, Transense earns residual royalty income from Bridgestone iTrack - a tyre monitoring system for off-highway vehicles that was developed by Translogik. The associated sales, support and development infrastructure were sold to Bridgestone Corporation, the world's largest tyre producer, in June 2020, and the intellectual property was licensed exclusively to Bridgestone under a ten-year deal expiring in 2030.

Find out more at: https://www.transense.com/

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAKABQCBKDDOK
Date   Source Headline
13th Dec 20119:34 amRNSExtension of offer period
12th Dec 20117:00 amRNSExclusive Distribution Agreement in Brazil
8th Dec 20117:00 amRNSStrategic Partnership in China
7th Dec 20117:00 amRNSStrategic Partnership
23rd Nov 20117:00 amRNSOtraco iTrack Trial
21st Nov 201110:00 amRNSProposed Fundraising - Replacement
21st Nov 20117:00 amRNSProposed Fundraising
20th Oct 20117:00 amRNSContract - Pirelli Brazil
30th Sep 20117:00 amRNSHalf Yearly Report
28th Sep 20117:00 amRNSNew Trading Division
27th Sep 20117:00 amRNSShare Allotment
26th Sep 20117:00 amRNSUpdate
16th Sep 20118:38 amRNSDirector/PDMR Shareholding
16th Aug 201111:32 amRNSJoint Development Agreement - McLaren Electronics
23rd Jun 20092:48 pmRNSDirector/PDMR Shareholding
8th Jun 20097:00 amRNSRe Translogik Limited
29th Apr 20091:08 pmRNSJt Development with McLaren Electronic Systems Ltd
7th Apr 20097:00 amRNSFinal Results
6th Mar 200911:18 amRNSNotice of Preliminary Results
4th Feb 20095:00 pmRNSDirector/PDMR Shareholding
2nd Feb 20092:50 pmRNSGrant of Options
30th Jan 20092:37 pmRNSDirectorate Change
30th Jan 20091:47 pmRNSContract Win
12th Jan 20091:12 pmRNSHolding(s) in Company
22nd Dec 20083:33 pmRNSWaiver & Grant of New Options
12th Nov 200811:50 amRNSUpdate re Vectron International
21st Oct 20082:17 pmRNSHolding(s) in Company
20th Oct 200812:52 pmRNSDirector/PDMR Shareholding
17th Oct 20087:30 amRNSResponse to share price movement
13th Oct 200810:04 amRNSHolding(s) in Company
9th Oct 200810:09 amRNSHolding(s) in Company
19th Sep 200812:07 pmRNSHolding(s) in Company
16th Sep 20082:52 pmRNSDirector/PDMR Shareholding
4th Sep 20087:00 amRNSInterim Results
29th Aug 20083:45 pmRNSNotice of Results
26th Aug 20083:58 pmRNSHolding(s) in Company
30th Jul 200812:01 pmRNSHolding(s) in Company
29th Jul 20082:29 pmRNSHolding(s) in Company
15th Jul 20082:00 pmRNSRe Agreement
25th Jun 20087:00 amRNSDirector/PDMR Shareholding
2nd Jun 20087:19 amRNSDirectorate Change
15th Apr 20082:58 pmRNSDirector/PDMR Shareholding
15th Apr 200812:46 pmRNSPreliminary Results
10th Apr 20089:05 amRNSNotice of Results
4th Apr 20083:49 pmRNSHolding(s) in Company
3rd Apr 200812:47 pmRNSDirectorate Change
20th Mar 20084:24 pmRNSHolding(s) in Company
20th Mar 20084:19 pmRNSHolding(s) in Company-Amend
19th Mar 20084:00 pmRNSTotal Voting Rights
18th Mar 20082:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.